JP2024504902A5 - - Google Patents
Info
- Publication number
- JP2024504902A5 JP2024504902A5 JP2023532743A JP2023532743A JP2024504902A5 JP 2024504902 A5 JP2024504902 A5 JP 2024504902A5 JP 2023532743 A JP2023532743 A JP 2023532743A JP 2023532743 A JP2023532743 A JP 2023532743A JP 2024504902 A5 JP2024504902 A5 JP 2024504902A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- weight
- amount
- contained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2020/050050 WO2022119430A1 (es) | 2020-12-04 | 2020-12-04 | Composición farmacéutica sólida recubierta y estable de un analgésico opioide y un antiepiléptico para el dolor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024504902A JP2024504902A (ja) | 2024-02-02 |
| JP2024504902A5 true JP2024504902A5 (https=) | 2025-05-13 |
| JP7720911B2 JP7720911B2 (ja) | 2025-08-08 |
Family
ID=81853431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532743A Active JP7720911B2 (ja) | 2020-12-04 | 2020-12-04 | 痛みに対するオピオイド鎮痛薬と抗てんかん薬のコーティングされた安定な固体医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240000727A1 (https=) |
| EP (1) | EP4230199A4 (https=) |
| JP (1) | JP7720911B2 (https=) |
| KR (1) | KR20230117591A (https=) |
| CA (1) | CA3199166A1 (https=) |
| CO (1) | CO2023008896A2 (https=) |
| DO (1) | DOP2023000095A (https=) |
| MX (1) | MX2022015331A (https=) |
| PE (2) | PE20252763A1 (https=) |
| WO (1) | WO2022119430A1 (https=) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5637767A (en) | 1995-06-07 | 1997-06-10 | Warner-Lambert Company | Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid |
| US20020187996A1 (en) | 2001-05-14 | 2002-12-12 | Dewey Stephen L. | Prevention of addiction in pain management |
| KR20060108692A (ko) | 2003-10-31 | 2006-10-18 | 알자 코포레이션 | 메트포르민의 개선된 흡수를 위한 조성물 및 제형 |
| MX2007008833A (es) | 2005-01-21 | 2008-03-25 | Pharmanova Inc | Formulaciones farmaceuticas y metodos de uso. |
| JP2007018123A (ja) | 2005-07-06 | 2007-01-25 | Kyocera Mita Corp | 画像処理装置、及び画像処理システム |
| MXPA05011735A (es) | 2005-11-01 | 2007-04-30 | Leopoldo Espinosa Abdala | Composiciones farmaceuticas que comprenden combinaciones de analgesicos y anticonvulsivantes para el tratamiento del dolor agudo y cronico. |
| DE102007019071A1 (de) | 2007-04-23 | 2008-10-30 | Ratiopharm Gmbh | Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin |
| CL2008003800A1 (es) | 2007-12-21 | 2010-01-22 | Synthon Bv | Sal de acido sulfonico de pregabalina, procedimiento de preparacion, composicion farmaceutica, util para tratar trastornos neuropsiquiatricos, esquizofrenia, epilepsia, fibromialgia, trastorno de ansiedad generalizada, trastorno de panico y fobia social y dolor por ejemplo dolor neuropatico. |
| TR200909613A1 (tr) | 2009-12-22 | 2011-07-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Pregabalinin farmasötik bileşimleri. |
| AU2011276170B2 (en) | 2010-07-06 | 2016-03-10 | Grunenthal Gmbh | Novel gastro- retentive dosage forms comprising a GABA Analog and an opioid |
| US20130189354A1 (en) | 2010-10-07 | 2013-07-25 | Trinity Laboratories, Inc., | Novel Pharmaceutical Compositions for Treating Chronic Pain and Pain Associated with Neuropathy |
| US20150313892A1 (en) * | 2014-02-07 | 2015-11-05 | Trinity Laboratories, Inc. | Pharmaceutical compositions for treating pain associated with dysmenorrhea |
| WO2018015946A1 (en) | 2016-07-17 | 2018-01-25 | Mapi Pharma Ltd. | Extended release dosage forms of pregabalin |
| MX2017016720A (es) | 2017-12-19 | 2019-06-20 | Monte Verde S A | Composición farmacéutica que contiene un analgésico de tipo opioide en combinación con un análogo del ácido g-aminobutírico (gaba). |
| KR20190075718A (ko) * | 2017-12-21 | 2019-07-01 | 주식회사 네비팜 | 용출율이 개선된 트라마돌 또는 이의 약학적으로 허용가능한 염 및 프레가발린 또는 이의 약학적으로 허용가능한 염을 포함하는 다층 제제 |
| WO2020044070A1 (es) * | 2018-08-30 | 2020-03-05 | Grünenthal GmbH | Combinación farmacéutica sinérgica que comprende tramadol clorhidrato y pregabalina, y su uso para el tratamiento del dolor neuropático |
-
2020
- 2020-12-04 US US18/255,244 patent/US20240000727A1/en active Pending
- 2020-12-04 CA CA3199166A patent/CA3199166A1/en active Pending
- 2020-12-04 JP JP2023532743A patent/JP7720911B2/ja active Active
- 2020-12-04 EP EP20964395.6A patent/EP4230199A4/en active Pending
- 2020-12-04 MX MX2022015331A patent/MX2022015331A/es unknown
- 2020-12-04 KR KR1020237022683A patent/KR20230117591A/ko active Pending
- 2020-12-04 WO PCT/MX2020/050050 patent/WO2022119430A1/es not_active Ceased
-
2023
- 2023-05-12 DO DO2023000095A patent/DOP2023000095A/es unknown
- 2023-07-04 CO CONC2023/0008896A patent/CO2023008896A2/es unknown
- 2023-07-04 PE PE2023002012A patent/PE20252763A1/es unknown
- 2023-07-04 PE PE2023002013A patent/PE20252750A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011500583A5 (https=) | ||
| JP2021512117A5 (https=) | ||
| JP2015091822A5 (https=) | ||
| JP6814886B2 (ja) | ベンゾイミダゾール誘導体を含む新規な製剤 | |
| JP2023536667A5 (https=) | ||
| JP2021512869A5 (https=) | ||
| EP3326619B1 (en) | Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine | |
| RU2003126177A (ru) | Способ приготовления негигроскопичной композиции вальпроата натрия | |
| JP2024504902A5 (https=) | ||
| US9132132B2 (en) | Pharmaceutical compositions of linezolid | |
| JP2018530566A5 (https=) | ||
| US11576917B2 (en) | Pharmaceutical compositions comprising Ibrutinib | |
| WO2020005189A2 (en) | Solid oral pharmaceutical compositions comprising teriflunomide | |
| WO2016079687A1 (en) | Oral pharmaceutical composition of teriflunomide | |
| JP2023551712A5 (https=) | ||
| EP2801352B1 (en) | Orally disintegrating formulations of Lacosamid | |
| JP2018145095A (ja) | エルロチニブ塩酸塩含有医薬組成物 | |
| EP3318279B1 (en) | Solid oral pharmaceutical compositions of lurasidone hydrochloride | |
| WO2011093828A2 (en) | Solid dosage forms comprising cefprozil | |
| JP7226697B2 (ja) | ブロナンセリン含有錠剤 | |
| EP2959889A1 (en) | Orally disintegrating formulations of loxoprofen | |
| US20150328215A1 (en) | Stable amorphous raltegravir potassium premix and process for the preparation thereof | |
| WO2015069203A1 (en) | Capsule comprising rupatadine fumarate and montelukast sodium | |
| JP2020090464A5 (https=) | ||
| US20130143857A1 (en) | Pharmaceutical compositions of cefditoren pivoxil |